2022
DOI: 10.1016/j.atherosclerosis.2022.03.030
|View full text |Cite
|
Sign up to set email alerts
|

Preclinical atherosclerosis and cardiovascular events: Do we have a consensus about the role of preclinical atherosclerosis in the prediction of cardiovascular events?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
15
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
9
1

Relationship

3
7

Authors

Journals

citations
Cited by 25 publications
(16 citation statements)
references
References 131 publications
0
15
1
Order By: Relevance
“…Interestingly, as opposed to diagnosed (self-reported) dyslipidemia, none of the traditional lipid markers (LDL-C, HDL-C, and triglycerides) alone predicted coronary calcifications in our study, which is a likely result of selection bias. Patients referred for calcium scanning as per guidelines [ 30 ] fall in the intermediate-risk category (i.e., 1-5% predicted 10-year cardiovascular mortality rate in our study) with comparable lipid profiles (as depicted by low to moderate lipid derangements and relatively narrow value ranges in our study population). The clinical goal for subclinical atherosclerosis detection is lipid-lowering therapy initiation in patients below lipid thresholds; in this context, our findings suggest lipid subfraction measurement may improve prediction of subclinical coronary atherosclerosis in intermediate-risk populations.…”
Section: Discussionmentioning
confidence: 56%
“…Interestingly, as opposed to diagnosed (self-reported) dyslipidemia, none of the traditional lipid markers (LDL-C, HDL-C, and triglycerides) alone predicted coronary calcifications in our study, which is a likely result of selection bias. Patients referred for calcium scanning as per guidelines [ 30 ] fall in the intermediate-risk category (i.e., 1-5% predicted 10-year cardiovascular mortality rate in our study) with comparable lipid profiles (as depicted by low to moderate lipid derangements and relatively narrow value ranges in our study population). The clinical goal for subclinical atherosclerosis detection is lipid-lowering therapy initiation in patients below lipid thresholds; in this context, our findings suggest lipid subfraction measurement may improve prediction of subclinical coronary atherosclerosis in intermediate-risk populations.…”
Section: Discussionmentioning
confidence: 56%
“…The present study has some limitations. Perhaps the most important one is the fact that until relatively recently there was a lack of IMT measurement standardization (method, mean/maximal thickness, carotid segment, including or excluding plaque) which could influence the predictive value in CHD risk estimation in different studies; therefore, this might also have an impact on the results of this meta-analysis [ 70 ]. In addition, according to the observational design of the included studies, we could not perform a comparative evaluation of the effects of bariatric surgery and medical treatment on IMT.…”
Section: Discussionmentioning
confidence: 99%
“…The predictive value of carotid intima-media thickness for CAD is controversial [20]. Although some prospective studies have shown that it increases the predictive power of traditional risk prediction models [6, 21,22], others cannot con rm this [23].…”
Section: Discussionmentioning
confidence: 99%